“The opioid epidemic in New York State is an unprecedented crisis, and it is critical to ensure that providers have as many options as possible to treat patients in the most effective way, ” Howard Zucker, MD, state health commissioner, told Iohud. “As research indicates that marijuana can reduce the use of opioids, adding opioid use as a qualifying condition for medical marijuana has the potential to help save countless lives across the state.”
New York state fits the ongoing trend of governmental actions substituting opioid use with medical marijuana, despite little scientific evidence, which is one of the key reasons many New York physicians show reluctance to the new program.
More articles on opioids:
Chicago licenses 1,500 pharma reps to help fight opioid epidemic
27K deaths attributed to fentanyl and new synthetic opioids in 2017
These 3 opioids were most commonly used by surgery patients preoperatively
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
